Literature DB >> 18391424

Preliminary time-of-flight neutron diffraction study of human deoxyhemoglobin.

A Y Kovalevsky1, T Chatake, N Shibayama, S-Y Park, T Ishikawa, M Mustyakimov, S Z Fisher, P Langan, Y Morimoto.   

Abstract

Human hemoglobin (HbA) is an intricate system that has evolved to efficiently transport oxygen molecules (O(2)) from lung to tissue. Its quaternary structure can fluctuate between two conformations, T (tense or deoxy) and R (relaxed or oxy), which have low and high affinity for O(2), respectively. The binding of O(2) to the heme sites of HbA is regulated by protons and by inorganic anions. In order to investigate the role of the protonation states of protein residues in O(2) binding, large crystals of deoxy HbA (approximately 20 mm(3)) were grown in D(2)O under anaerobic conditions for neutron diffraction studies. A time-of-flight neutron data set was collected to 1.8 A resolution on the Protein Crystallography Station (PCS) at the spallation source run by Los Alamos Neutron Science Center (LANSCE). The HbA tetramer (64.6 kDa; 574 residues excluding the four heme groups) occupies the largest asymmetric unit (space group P2(1)) from which a high-resolution neutron data set has been collected to date.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391424      PMCID: PMC2374244          DOI: 10.1107/S1744309108005137

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  21 in total

1.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Authors:  J MONOD; J WYMAN; J P CHANGEUX
Journal:  J Mol Biol       Date:  1965-05       Impact factor: 5.469

2.  Locating active-site hydrogen atoms in D-xylose isomerase: time-of-flight neutron diffraction.

Authors:  Amy K Katz; Xinmin Li; H L Carrell; B Leif Hanson; Paul Langan; Leighton Coates; Benno P Schoenborn; Jenny P Glusker; Gerard J Bunick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-17       Impact factor: 11.205

3.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

4.  Deuterium exchange in lysozyme at 1.4-A resolution.

Authors:  S A Mason; G A Bentley; G J McIntyre
Journal:  Basic Life Sci       Date:  1984

5.  Hemoglobin tertiary structural change on ligand binding. Its role in the co-operative mechanism.

Authors:  B R Gelin; A W Lee; M Karplus
Journal:  J Mol Biol       Date:  1983-12-25       Impact factor: 5.469

6.  Protonation states of buried histidine residues in human deoxyhemoglobin revealed by neutron crystallography.

Authors:  Toshiyuki Chatake; Naoya Shibayama; Sam-Yong Park; Kazuo Kurihara; Taro Tamada; Ichiro Tanaka; Nobuo Niimura; Ryota Kuroki; Yukio Morimoto
Journal:  J Am Chem Soc       Date:  2007-11-09       Impact factor: 15.419

7.  Nuclear magnetic resonance and neutron diffraction studies of the complex of ribonuclease A with uridine vanadate, a transition-state analogue.

Authors:  B Borah; C W Chen; W Egan; M Miller; A Wlodawer; J S Cohen
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

8.  Neutron diffraction identifies His 57 as the catalytic base in trypsin.

Authors:  A A Kossiakoff; S A Spencer
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  Preliminary neutron and ultrahigh-resolution X-ray diffraction studies of the aspartic proteinase endothiapepsin cocrystallized with a gem-diol inhibitor.

Authors:  Han-Fang Tuan; Peter Erskine; Paul Langan; Jon Cooper; Leighton Coates
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-30

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  7 in total

1.  Preliminary neutron and X-ray crystallographic studies of equine cyanomethemoglobin.

Authors:  A Y Kovalevsky; S Zoe Fisher; Sean Seaver; Marat Mustyakimov; Narayanasami Sukumar; Paul Langan; Timothy C Mueser; B Leif Hanson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-31

2.  Hemoglobin redux: combining neutron and X-ray diffraction with mass spectrometry to analyse the quaternary state of oxidized hemoglobins.

Authors:  Timothy C Mueser; Wendell P Griffith; Andrey Y Kovalevsky; Jingshu Guo; Sean Seaver; Paul Langan; B Leif Hanson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-10-20

3.  A preliminary neutron diffraction study of gamma-chymotrypsin.

Authors:  Walter R P Novak; Aaron G Moulin; Matthew P Blakeley; Ilme Schlichting; Gregory A Petsko; Dagmar Ringe
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-02-26

4.  Protonation states of histidine and other key residues in deoxy normal human adult hemoglobin by neutron protein crystallography.

Authors:  Andrey Kovalevsky; Toshiyuki Chatake; Naoya Shibayama; Sam Yong Park; Takuya Ishikawa; Marat Mustyakimov; S Zoe Fisher; Paul Langan; Yukio Morimoto
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-10-20

5.  Macromolecular neutron crystallography at the Protein Crystallography Station (PCS).

Authors:  Andrey Kovalevsky; Zoe Fisher; Hannah Johnson; Marat Mustyakimov; Mary Jo Waltman; Paul Langan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-10-20

Review 6.  Neutron crystallography: opportunities, challenges, and limitations.

Authors:  Matthew P Blakeley; Paul Langan; Nobuo Niimura; Alberto Podjarny
Journal:  Curr Opin Struct Biol       Date:  2008-08-07       Impact factor: 6.809

7.  Protein structures by spallation neutron crystallography.

Authors:  Paul Langan; Zoë Fisher; Andrii Kovalevsky; Marat Mustyakimov; Amanda Sutcliffe Valone; Cliff Unkefer; Mary Jo Waltman; Leighton Coates; Paul D Adams; Pavel V Afonine; Brad Bennett; Chris Dealwis; Benno P Schoenborn
Journal:  J Synchrotron Radiat       Date:  2008-04-18       Impact factor: 2.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.